Share Your Diagnosis
Patient or clinician submits genetic test results through our secure, HIPAA-compliant portal.
How It Works
From diagnosis to dose, end to end.
Here's what happens when you come to Nome.
The Process
One workflow. Five steps.
AI Analysis (Togo Platform)
Our platform evaluates your specific mutations against multiple therapeutic options, including ASOs, gene therapy, base editing, existing clinical trials and drug repurposing.
Expert Review + Summary Report
A PhD scientist validates every AI-generated finding. You receive a free Summary Report with a plain-English overview of your options.
Free Summary Report delivered here. No cost, no obligation.
The Blueprint
A deep-dive action plan with execution-ready next steps, timelines, cost projections, and mechanism-level rationale with inline citations. 30 to 60 days to deliver.
Program Management
Nome manages the full therapeutic development process: vendor selection, preclinical work, regulatory filings, manufacturing, and clinical coordination.
Your Report
The report you will receive from Nome.
Nome analyzes your specific genetic mutation to identify which genetic medicine options might be right for you. All our work is backed by literature and reviewed by a PhD before we share it with you — high-quality insights you can take next-step action on.
Sample Report Output
Modality
Amenability
Confidence
Status
ASO (Exon Skipping)
87
High
Actionable
Clinical Trial Match
78
High
Actionable
Gene Therapy (AAV)
62
Moderate
Evaluate Further
Base Editing (ABE)
41
Moderate
Evaluate Further
Drug Repurposing
23
Low
Low Feasibility
Each patient receives a scored assessment across all viable therapeutic modalities for their specific mutation.
